Literature DB >> 2644976

Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells.

F J Bot1, L van Eijk, L Broeders, L A Aarden, B Löwenberg.   

Abstract

We examined the in vitro stimulative effects of recombinant human interleukin-6 (IL-6, or interferon-beta 2) on purified human bone marrow progenitor cells. IL-6 alone or in combination with erythropoietin (Epo), IL-3, GM-CSF, or G-CSF did not induce colony formation. However, IL-6 strongly synergized with M-CSF in stimulating macrophage colony formation (colony numbers and size). The magnitude of IL-6 synergism with M-CSF was dose dependent; maximal potentiation of M-colony formation was evident at approximately 100 to 1,000 U/mL IL-6. When the addition of IL-6 to M-CSF-supplemented cultures was delayed for more than one day after the beginning of culture, enhancement of macrophage colony formation was lost. IL-6 stimulation of M-CSF-responsive colony formation was not apparent when nonpurified marrow cells were plated, most likely due to endogenous IL-6 release. These observations suggest that IL-6, in addition to playing a role in B-lymphocyte proliferation can potentiate the human immune defence mechanism by stimulating monocyte-macrophage development as well.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644976

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

2.  Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.

Authors:  R J Hill; M K Warren; J Levin
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  Design of recombinant stem cell factor-macrophage colony stimulating factor fusion proteins and their biological activity in vitro.

Authors:  Tao Chen; Jie Yang; Yuelang Wang; Chenyang Zhan; Yuhui Zang; Junchuan Qin
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

4.  Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.

Authors:  K Akashi; T Shibuya; M Harada; Y Takamatsu; N Uike; T Eto; Y Niho
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

5.  Role of macrophage colony-stimulating factor in the differentiation and expansion of monocytes and dendritic cells from CD34+ progenitor cells.

Authors:  A W Kamps; D Hendriks; J W Smit; E Vellenga
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

Review 6.  Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growth.

Authors:  J Bauer
Journal:  Klin Wochenschr       Date:  1989-07-17

7.  Elevated serum interleukin-6 levels in patients with acute hepatitis.

Authors:  Y Sun; K Tokushige; E Isono; K Yamauchi; H Obata
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

Review 8.  Interleukin-6 in clinical medicine.

Authors:  J Bauer; F Herrmann
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

9.  Structural and functional studies on the human hepatic interleukin-6 receptor. Molecular cloning and overexpression in HepG2 cells.

Authors:  H Schooltink; T Stoyan; D Lenz; H Schmitz; T Hirano; T Kishimoto; P C Heinrich; S Rose-John
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

10.  Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component.

Authors:  M Kopf; S Herren; M V Wiles; M B Pepys; M H Kosco-Vilbois
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.